Many nanotechnology researchers are focused on developing ways to preemptively recognize and eliminate cancer cells and tumors from the body. Still, there are nanotechnologies that are being used to target specific cancers directly. This includes using known nanotechnology medical applications including colloidal nanoshells and nanoparticles as well newly developed drugs and drug implementation systems. In developmental research colloidal gold has shown to be effective in treating lung cancer. While two specific cancer fighting drugs have been also been developed to fight lung as well as pancreatic cancer, and ovarian cancer and multiple myeloma. More research into methods for using and developing nanotechnology cancer detection is still undergoing. To get detailed information and descriptions of the latest nanomedicine products contact a nanotechnology company today.
Nanomedicine treatments and technologies are being developed to fight a diverse amount of cancers and tumors. In fact, some of the research that has been done is focused on creating mechanisms that detect all cancerous cells before they become dangerous and eliminating them. The most applicable form of this technology are magnetic nanoparticles and in body nanosensors. Magnetic nanoparticles use binding elements to seek out and stick to specific cancer cells; this could mean designing them to find specific cancers a patient is worried about, or targeting cells that display common cancerous characteristics. The nanoparticles then can either destroy the cancer or be removed from the body using the application of a magnetic field. These anti-tumor medicines are aimed at killing cancer cells before they take hold in the body and develop.
Today, there are anti-cancer nanomedicines and drugs being developed by researchers and already available for use. Specific drugs fight lung, pancreatic and ovarian cancer as well as multiple myeloma. In addition, colloidal gold is a nanomedicine that researchers hope one day will become a staple in all cancer treatments that has already shown promising results fighting lung cancer in trials. Colloidal gold nanoshells are nanoscale sized particles of gold that are injected into the body that bind to cancer cells and can destroy them using heat. Abraxane and Doxil are two new cancer drugs have just been approved by the FDA. Abraxane incorporates nanotechnology lung cancer treatments by using nanoparticles as a delivery system to help administer the medicine. Where Doxil uses a nanotechnology composed compound to increase the effectiveness of the delivery and preservation of the medicine for the treatment of ovarian cancer and multiple myeloma.
For more information on the groundbreaking drugs and nanotechnology cancer surgery treatments being developed by medical researchers, visit the website of a nanotechnology company for updated lists of current technologies and their availability.